Generation Bio Co 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 18.72, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Generation Bio Co in Sep 30 2025 quarter, has decreased to 19 days, compared to 22 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 63 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 705, from overall ranking in the second quarter 2025 at 782.

What is Receivable Turnover Ratio?
What is Generation Bio Co Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GBIO Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-82.32 %	-80.85 %	-	-	235.15 %
Y / Y Revenue Change	-78.9 %	-81.3 %	114.91 %	45.52 %	252 %
Receivable Turnover Ratio (TTM)	18.72	16.7	15.93	16.67	20.94
GBIO's Total Ranking	# 705	# 782	# 845	# 979	# 716
Accounts Receivable average collection period days	19	22	23	22	17
Seq. Receivable Change	52.73 %	-81.61 %	13.73 %	-44.67 %	65.45 %
Seq. Revenue Change	108.37 %	-91.23 %	108.29 %	-44.56 %	84.65 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 28
Healthcare Sector	# 64
Overall Market	# 705

Receivable Turnover Ratio Statistics
High	Average	Low
39.85	22.17	15.93
(Mar 31 2024)		(Mar 31 2025)

GBIO Company Profile • Back to GBIO Efficiency Comparisons • Compare GBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Generation Bio Co 's Accounts Receivable	$ 0 Millions	Visit GBIO's Balance sheet
Generation Bio Co 's Sales TTM	$ 15 Millions	Visit GBIO's Income Statement
Sources of GBIO's Revenues		Visit GBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GBIO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GBIO's Growth Rates	GBIO's Roa	GBIO's Inventory Turnover Ratio	GBIO's Dividend Comparisons
GBIO's Profitability Ratios	GBIO's Roi	GBIO's Asset Turnover Ratio	GBIO's Dividend Growth
GBIO's Valuation Ratios	GBIO's Roe	GBIO's Financial Strength Ratios	GBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Logicmark Inc	107.06	$ 10.609 Millions	$ 0.099 Millions
Silence Therapeutics Plc	91.76	$ 25.830 Millions	$ 0.282 Millions
Stoke Therapeutics Inc	88.94	$ 205.632 Millions	$ 2.312 Millions
Sbc Medical Group Holdings Incorporated	88.32	$ 176.776 Millions	$ 2.002 Millions
Blue Water Vaccines Inc	86.30	$ 1.224 Millions	$ 0.014 Millions
Aclaris Therapeutics Inc	82.63	$ 15.741 Millions	$ 0.191 Millions
Lifevantage Corp	76.51	$ 227.759 Millions	$ 2.977 Millions
Sangamo Therapeutics Inc	73.59	$ 32.875 Millions	$ 0.447 Millions
Atara Biotherapeutics Inc	69.93	$ 214.503 Millions	$ 3.068 Millions
Eyepoint Inc	62.29	$ 42.340 Millions	$ 0.680 Millions
Caribou Biosciences Inc	55.83	$ 9.295 Millions	$ 0.167 Millions
Brookdale Senior Living Inc	55.20	$ 3,220.921 Millions	$ 58.351 Millions
Cytomx Therapeutics Inc	53.12	$ 113.631 Millions	$ 2.139 Millions
Agape Atp Corporation	46.97	$ 1.485 Millions	$ 0.032 Millions
Humacyte Inc	46.85	$ 22.958 Millions	$ 0.490 Millions
Arvinas Inc	46.44	$ 312.300 Millions	$ 6.725 Millions
Solana Company	45.90	$ 0.941 Millions	$ 0.021 Millions
Fortrea Holdings Inc	45.15	$ 2,759.900 Millions	$ 61.125 Millions
Marpai Inc	38.88	$ 20.702 Millions	$ 0.533 Millions
Nature s Sunshine Products inc	38.67	$ 474.009 Millions	$ 12.258 Millions
National Vision Holdings Inc	38.15	$ 1,861.626 Millions	$ 48.800 Millions
X4 Pharmaceuticals Inc	37.60	$ 33.979 Millions	$ 0.904 Millions
Kyntra Bio Inc	37.51	$ 8.298 Millions	$ 0.221 Millions
Orchestra Biomed Holdings Inc	35.67	$ 2.818 Millions	$ 0.079 Millions
Lineage Cell Therapeutics Inc	35.06	$ 10.816 Millions	$ 0.309 Millions
Wave Life Sciences Ltd	33.51	$ 109.230 Millions	$ 3.260 Millions
Invo Fertility Inc	32.11	$ 6.944 Millions	$ 0.216 Millions
Metagenomi Therapeutics Inc	30.14	$ 30.913 Millions	$ 1.025 Millions
Vireo Growth Inc.	29.54	$ 189.242 Millions	$ 6.407 Millions
Longeveron Inc	29.33	$ 1.437 Millions	$ 0.049 Millions

Date modified: 2026-10-05T11:03:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.